{
    "clinical_study": {
        "@rank": "36732", 
        "acronym": "IDT-1206-BA", 
        "brief_summary": {
            "textblock": "In this clinical trial, accuracy evaluation of Bayer Contour XT blood glucose monitoring\n      system and blood glucose monitoring systems from other companies  across the overall tested\n      glucose range will be performed."
        }, 
        "brief_title": "Analytical Performance Evaluation of Blood Glucose Monitoring Systems- Investigator Sponsored Contour\u00ae XT Comparator Study - Ulm Germany", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or older\n\n          -  Male or female subjects with type 1 or type 2 diabetes or healthy subjects\n\n          -  For BG adjustment people with type 1 diabetes\n\n        Exclusion Criteria:\n\n          -  Severe acute illness that, in the opinion of the Investigator, might pose additional\n             risk to the patient\n\n          -  Chronic illness that, in the opinion of the Investigator, might pose additional risk\n             to the patient\n\n          -  Current condition that, in the opinion of the Investigator, doesn't enable subject to\n             participate in the study\n\n          -  For BG adjustment people with type 1 diabetes without CHD, condition after myocardial\n             infarction, PAOD, cerebral events or hypoglycaemia unawareness\n\n          -  Legal incompetence or limited legal competence\n\n          -  Age < 18 years\n\n          -  Dependency from the sponsor or the clinical investigator\n\n          -  Mental incapacity or language barriers precluding adequate compliance with the study\n             procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789021", 
            "org_study_id": "IDT-1206-BA"
        }, 
        "intervention": {
            "intervention_name": "4 blood glucose monitoring systems", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "blood glucose monitoring systems", 
            "ISO 15197", 
            "system accuracy"
        ], 
        "lastchanged_date": "May 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ulm", 
                    "country": "Germany", 
                    "zip": "89081"
                }, 
                "name": "Institut f\u00fcr Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universit\u00e4t Ulm"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "official_title": "Analytical Performance Evaluation of Blood Glucose Monitoring Systems", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Germany: Ethics Commission", 
                "Germany: Federal Institute for Drugs and Medical Devices"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Differences in accuracy between blood glucose monitoring systems across the overall tested glucose range by comparing the mean absolute value of relative (percent) difference (MARD) between the meter value and the reference value", 
            "time_frame": "For each subject, the experimental phase has an expected duration of up to 6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789021"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Institut f\u00fcr Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universit\u00e4t Ulm", 
        "sponsors": {
            "collaborator": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Institut f\u00fcr Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universit\u00e4t Ulm", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}